What is the appropriate management of acute kidney injury in a pregnant woman?

Management of Acute Kidney Injury in Pregnancy

For pregnant women with AKI, management must focus on identifying and treating the underlying cause—particularly hypertensive disorders of pregnancy—while providing supportive care with careful fluid resuscitation, avoiding nephrotoxic medications (especially ACE inhibitors and ARBs), and considering early dialysis when indicated, with prompt delivery being the definitive treatment for pregnancy-specific causes like preeclampsia.

Immediate Assessment and Risk Stratification

When AKI is suspected in pregnancy, immediately assess for:

• Gestational age and timing: First trimester AKI suggests hyperemesis gravidarum, while second/third trimester points to preeclampsia, HELLP syndrome, acute fatty liver of pregnancy, or thrombotic microangiopathies 1, 2
• Blood pressure: Severe hypertension (≥160/110 mmHg) requires urgent treatment in a monitored setting 3
• Proteinuria: Check urinalysis at each visit; proteinuria >300 mg/24h after 20 weeks indicates preeclampsia 3
• Laboratory markers: Obtain hemoglobin, platelet count, liver transaminases, uric acid, and creatinine at minimum 3

The most common causes of pregnancy-related AKI are hypertensive disorders (preeclampsia/HELLP), obstetric hemorrhage, and sepsis 1, 4.

Cause-Specific Treatment Strategies

Hypertensive Disorders and Preeclampsia

Blood pressure control is critical but delivery is the only definitive cure 5, 6:

• For severe hypertension (≥160/110 mmHg): Use oral nifedipine, IV labetalol, or IV hydralazine 3
• Target BP: 110-140/85 mmHg to prevent maternal complications without compromising placental perfusion 3
• Magnesium sulfate: Give for seizure prophylaxis in severe preeclampsia—loading dose 4g IV or 10g IM, followed by 5g IM every 4 hours or 1g/h infusion until delivery and 24 hours postpartum 3
• Steroids: Administer for 48 hours to accelerate fetal lung maturation if <34 weeks gestation 5
• Delivery timing: Prompt delivery is indicated for worsening maternal condition, end-organ dysfunction, or fetal distress 5

Volume Management

Fluid resuscitation must be judicious 5:

• Pregnant women with renal disease often have volume overload that reduces drug responsiveness
• May require salt restriction and loop diuretics (furosemide has been used safely in pregnancy complicated by renal or cardiac failure) 5
• Avoid aggressive fluid resuscitation that could precipitate pulmonary edema
• In preeclampsia with pulmonary edema, nitroglycerin is the drug of choice 7

Dialysis Considerations

Early and aggressive dialysis improves outcomes 3:

• For progressive renal disease in pregnancy, aim for approximately 36 hours per week of dialysis
• This aggressive prescription conveys the best maternal and fetal outcomes
• Do not delay dialysis initiation in pregnant women with standard indications

Medication Safety: Critical Contraindications

Absolutely contraindicated medications 5, 6, 8:

• ACE inhibitors and ARBs: Cause renal dysgenesis and fetotoxicity in second/third trimesters—discontinue immediately if pregnancy confirmed
• Direct renin inhibitors: Also strictly contraindicated
• Atenolol: Associated with fetal growth retardation related to treatment duration 7

Safe antihypertensive options 5, 6, 8:

• Methyldopa: First-line agent (750mg-4g/day in divided doses) with best long-term safety data
• Labetalol: Increasingly preferred (100mg twice daily up to 2400mg/day) due to fewer side effects
• Nifedipine: Safe but avoid sublingual/IV routes due to risk of excessive BP reduction
• Metoprolol: Recommended alternative beta-blocker

Specific Etiologies Requiring Targeted Therapy

Beyond preeclampsia, consider these diagnoses requiring specific interventions 9, 2:

• Glomerulonephritis: Steroids and immunosuppressive therapy
• Acute fatty liver of pregnancy: Prompt delivery
• Thrombotic thrombocytopenic purpura: Plasmapheresis
• Atypical hemolytic uremic syndrome: Eculizumab
• HELLP syndrome: Prompt delivery

Monitoring and Follow-Up

Close surveillance is essential 3:

• Monitor for superimposed preeclampsia with urinalysis at each visit
• Blood tests (Hb, platelets, liver enzymes, uric acid, creatinine) at 28 and 34 weeks minimum
• Fetal ultrasound from 26 weeks, every 2-4 weeks if normal, more frequently with suspected growth restriction
• Maternal and fetal outcomes are generally worse than general population even with mild chronic kidney disease 3

Multidisciplinary Team Approach

Management requires coordination between nephrologist, obstetrician, and neonatologist 9, 2. The complexity of balancing maternal renal function, blood pressure control, and fetal well-being necessitates this collaborative approach, particularly given that 20.4% of pregnant women with AKI require renal replacement therapy, with associated mortality of 19.4% 4.

Key Clinical Pitfalls to Avoid

• Do not restrict protein intake to prevent or delay dialysis 10
• Do not use diuretics as first-line agents for hypertension—they reduce plasma volume expansion and may promote preeclampsia 5
• Do not delay delivery when maternal condition worsens or end-organ dysfunction develops
• Do not underestimate the severity: Among obstetric ICU admissions, AKI incidence reaches 28% globally, with highest rates in Africa and Western Pacific regions 4